Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

GZPHF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$111,427$0$1,821,313$0
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$0-$2,607,876$0$0
Other Non-Cash$125,810$3,107,998-$5,718,571$0
Operating Cash Flow$237,237$500,122-$3,897,258$0
Investing Activities
PP&E Inv.-$58,703-$270,710-$226,496-$316,168
Net Acquisitions$3,135$0$0$0
Inv. Purchases-$512,827-$4,722,291-$1,240,000-$2,421,373
Inv. Sales/Matur.$702,755$1,004,141$725,432$1,012,105
Other Inv. Act.$2$4,738$2,411$1,296
Investing Cash Flow$134,362-$3,984,122-$738,652-$1,724,140
Financing Activities
Debt Repay.-$123,491$1,480,930$1,173,890-$755,853
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0-$655,868-$84,030-$769,135
Other Fin. Act.-$4,206$67,470-$64,082-$68,543
Financing Cash Flow-$127,697$892,533$1,025,778-$1,593,531
Forex Effect$51,282-$858$6,328$2,125
Net Chg. in Cash$295,185-$2,592,326-$3,603,804$878,243
Supplemental Information
Beg. Cash$1,629,409$12,699,135$16,302,939$15,424,696
End Cash$1,924,594$10,106,809$12,699,135$16,302,939
Free Cash Flow$178,534$229,412-$4,123,754$3,877,621